These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28011485)

  • 1. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
    Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
    Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic Acid Sensitizes Leukemia Lymphocytes to Barasertib and Everolimus by ROS-dependent Mechanism Without Affecting the Level of ROS and Viability of Normal Lymphocytes.
    Zhelev Z; Ivanova D; Lazarova D; Aoki I; Bakalova R; Saga T
    Anticancer Res; 2016 Apr; 36(4):1673-82. PubMed ID: 27069145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Pentose-phosphate Pathway Selectively Sensitizes Leukemia Lymphocytes to Chemotherapeutics by ROS-independent Mechanism.
    Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
    Anticancer Res; 2016 Nov; 36(11):6011-6020. PubMed ID: 27793928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib.
    Ivanova D; Zhelev Z; Lazarova D; Getsov P; Bakalova R; Aoki I
    Anticancer Res; 2018 Mar; 38(3):1407-1414. PubMed ID: 29491065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes.
    Ivanova D; Zhelev Z; Zlateva G; Lazarova D; Yaneva Z; Panovska R; Aoki I; Bakalova R
    Anticancer Res; 2022 Jan; 42(1):547-554. PubMed ID: 34969764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol Modulates the Redox-status and Cytotoxicity of Anticancer Drugs by Sensitizing Leukemic Lymphocytes and Protecting Normal Lymphocytes.
    Ivanova D; Zhelev Z; Semkova S; Aoki I; Bakalova R
    Anticancer Res; 2019 Jul; 39(7):3745-3755. PubMed ID: 31262901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deoxy-D-glucose Sensitizes Cancer Cells to Barasertib and Everolimus by ROS-independent Mechanism(s).
    Zhelev Z; Ivanova D; Aoki I; Saga T; Bakalova R
    Anticancer Res; 2015 Dec; 35(12):6623-32. PubMed ID: 26637878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
    Bakalova R; Semkova S; Ivanova D; Zhelev Z; Miller T; Takeshima T; Shibata S; Lazarova D; Aoki I; Higashi T
    Oxid Med Cell Longev; 2020; 2020():6212935. PubMed ID: 33204397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
    Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
    Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect.
    Büyükavci M; Ozdemir O; Buck S; Stout M; Ravindranath Y; Savaşan S
    Fundam Clin Pharmacol; 2006 Feb; 20(1):73-9. PubMed ID: 16448397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
    Khan S; Zafar A; Naseem I
    Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
    Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
    Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells.
    Uguz AC; Cig B; Espino J; Bejarano I; Naziroglu M; Rodríguez AB; Pariente JA
    J Pineal Res; 2012 Aug; 53(1):91-8. PubMed ID: 22288984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells.
    Wu CF; Hong C; Klauck SM; Lin YL; Efferth T
    J Ethnopharmacol; 2015 Dec; 176():55-68. PubMed ID: 26476154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
    PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3.
    Lanuti P; Bertagnolo V; Pierdomenico L; Bascelli A; Santavenere E; Alinari L; Capitani S; Miscia S; Marchisio M
    Cell Res; 2009 Sep; 19(9):1079-89. PubMed ID: 19564891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
    Zafar A; Singh S; Naseem I
    J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic killing of human leukemia cells by antioxidants and trichostatin A.
    Kang J; Chen J; Zhang D; Da W; Ou Y
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):537-45. PubMed ID: 15248029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.